共 65 条
[1]
Alfirevic Z., Kurjak A., Transvaginal colour Doppler ultrasound in normal and abnormal early pregnancy, Journal of Perinatal Medicine, 18, 3, pp. 173-180, (1990)
[2]
Bates S.M., Greer I.A., Pabinger I., Sofaer S., Hirsh J., Venous thromboembolism, thrombophilia, antithrombotic therapy, and pregnancy: American College of Chest Physicians evidence-based clinical practice guidelines (8th edition), Chest, 133, 6 SUPPL. 6, (2008)
[3]
Bertina R.M., Koeleman B.P.C., Koster T., Rosendaal F.R., Dirven R.J., De Ronde H., Van Der Velden P.A., Reitsma P.H., Mutation in blood coagulation factor V associated with resistance to activated protein C, Nature, 369, 6475, pp. 64-67, (1994)
[4]
Bick R.L., Recurrent miscarriage syndrome due to blood coagulation protein/platelet defects: Prevalence, treatment and outcome results, Clinical and Applied Thrombosis/Hemostasis, 6, 3, pp. 115-125, (2000)
[5]
Bogdanova N., Horst J., Chlystun M., Croucher P.J.P., Nebel A., Bohring A., Todorova A., Schreiber S., Gerke V., Krawczak M., Markoff A., A common haplotype of the annexin A5 (ANXA5) gene promoter is associated with recurrent pregnancy loss, Human Molecular Genetics, 16, 5, pp. 573-578, (2007)
[6]
Bosler D., Mattson J., Crisan D., Phenotypic heterogeneity in patients with homozygous prothrombin 20210AA genotype, J Mol Diagn, 4, pp. 420-425, (2006)
[7]
Branch D.W., Silver R.M., Blackwell J.L., Reading J.C., Scott J.R., Outcome of treated pregnancies in women with antiphospholipid syndrome: An update of the Utah experience, Obstet Gynecol, 80, pp. 614-620, (1992)
[8]
Brenner B., Sarig G., Weiner Z., Younis J., Blumenfeld Z., Lanir N., Thrombophilic polymorphisms are common in women with fetal loss without apparent cause, Thrombosis and Haemostasis, 82, 1, pp. 6-9, (1999)
[9]
Cattaneo M., Hyperhomocysteinemia, atherosclerosis and thrombosis, Thrombosis and Haemostasis, 81, 2, pp. 165-176, (1999)
[10]
Cattaneo M., Tsai M.Y., Bucciarelli P., Taioli E., Zighetti M.L., Bignell M., Mannucci P.M., A common mutation in the methylenetetrahydrofolate reductase gene (C677T) increases the risk for deep-vein thrombosis in patients with mutant factor V (factor V:Q<sup>506</sup>), Arteriosclerosis, Thrombosis, and Vascular Biology, 17, 9, pp. 1662-1666, (1997)

